CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 89 enrolled
Drug / intervention
Active Acupuncture +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03364127
NCT03364127N/ACompleted
CompareCT.gov

Double-blind Phase 2 RCT: Effect of Acupuncture on Patient Vulvodynia Outcomes

University of Illinois at Chicago·interventional·Posted Dec 6, 2017·Updated May 30, 2025

In Brief

A clinical study evaluating Active Acupuncture and Placebo Acupuncture for Vulvodynia and 2 related conditions. Completed, enrolled 89 participants across 1 site.

Detailed Summary

This study evaluates acupuncture for the treatment of vulvodynia; specifically if it reduces vulvar pain and pain with intercourse. It also examines how long the effect of acupuncture lasts in women with vulvodynia. Half of the women will receive acupuncture and the other half will receive placebo acupuncture. Women who get a reduction in pain will monitor there pain once a week for up to 12 weeks to see how long the acupuncture effect lasts.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVulvodynia, Vulvodynia, Generalized, Vulvar Vestibulitis
CountriesUnited States
CollaboratorsUniversity of Florida

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedDec 6, 2017
Enrollment StartFeb 23, 2018
Primary CompletionOct 26, 2022
Study CompletionNov 7, 2022
TodayJul 2, 2026
Enrollment to primary: 4.7 yearsPosted 8.6 years ago

Interventions

Active Acupunctureother

Active Acupuncture two times per week for 5 weeks

Placebo Acupunctureother

Placebo Acupuncture two times per week for 5 weeks